Meanwhile, PD-L1 on TAMs increased its binding to PD-1 on the surface of effector CD8+ T cells and CD4+ T cells, so it weakened the immune attack of CD8+ T cells and CD4+ T cells, and then mediated immune escape of colon cancer. Here, CD4 is linked to malignant colon neoplasm.